AI: Shifting Life Science from Experimentation to Prediction

​AI: Shifting Life Science from Experimentation to Prediction

​Exclusive Roundtable Dinner | San Diego

​Executive leaders from San Diego’s life science community are invited to an exclusive roundtable dinner on “AI: Shifting Life Science from Experimentation to Prediction.”

​This invitation-only event offers an opportunity for senior executives to engage in a thought-provoking discussion on how artificial intelligence is transforming the life sciences sector—from accelerating research to enabling predictive insights that redefine innovation and patient outcomes.

​A seasoned moderator will guide the conversation in a confidential, closed-door setting, fostering meaningful exchange and collaboration among peers.
Attendance is complimentary and by invitation only.

​Attendees

​This roundtable brings together senior leaders who are leveraging AI to drive innovation, ensure compliance, and shape the future of life sciences.

​
Current confirmed attendees include:

• ​VP, Wearables – Dexcom

• ​Director, Strategic Operations Lead – Bristol Myers Squibb (BMS)

• ​Head of Licensing – ResMed

• ​Director, Global R&D – Illumina

• ​Director, Global Competitive Intelligence – Dexcom

• ​Director of Operations – Valiance Clinical Research

• ​Vice President, Finance – Recursion

• ​CFO – Ionis Pharmaceuticals

• ​COO – Kaiser Permanente

​Agenda

​6:00 PM – Guest arrival and welcome drinks
6:30 PM – Opening remarks by The Ortus Club
6:40 PM – Introduction by RSM US
6:50 PM – Moderated discussion
7:20 PM – Appetizers served
7:50 PM – Discussion concludes; main course served
8:20 PM – Drinks and networking

​Discussion Topic

​AI: Shifting Life Science from Experimentation to Prediction

​Artificial intelligence is revolutionizing how life science organizations innovate, make decisions, and remain competitive in a rapidly evolving landscape.
AI is accelerating research, optimizing operations, and enabling more personalized patient outcomes. Yet, scaling AI adoption presents challenges—from regulatory compliance and data governance to ensuring ethical, transparent algorithmic use.

​As leaders navigate these complexities, they must also prepare for the next wave: autonomous systems, deep AI integration across R&D, and predictive insights driving precision and efficiency.

​This roundtable will explore:

• ​How executives are leveraging AI to accelerate innovation, strengthen decision-making, and gain competitive advantage

• ​Strategies for addressing regulatory, data governance, and implementation challenges unique to life sciences

• ​The future impact of AI and its implications for industry transformation

​Next Steps

​If you would like to join this exclusive dinner discussion, please request an invitation.
Attendance is complimentary for approved participants, and space is limited.

​Hosts

​RSM – A leading global provider of audit, tax, and consulting services for mid-market business leaders.

​Organiser

​The Ortus Club – Curators of executive knowledge-sharing discussions and private networking events worldwide.
Their mission is to foster open, strategic dialogue among senior decision-makers across industries.